全文获取类型
收费全文 | 10283篇 |
免费 | 721篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 326篇 |
妇产科学 | 255篇 |
基础医学 | 1826篇 |
口腔科学 | 263篇 |
临床医学 | 1224篇 |
内科学 | 2093篇 |
皮肤病学 | 289篇 |
神经病学 | 886篇 |
特种医学 | 620篇 |
外科学 | 1181篇 |
综合类 | 112篇 |
一般理论 | 3篇 |
预防医学 | 714篇 |
眼科学 | 112篇 |
药学 | 575篇 |
中国医学 | 10篇 |
肿瘤学 | 499篇 |
出版年
2021年 | 105篇 |
2020年 | 99篇 |
2019年 | 164篇 |
2018年 | 187篇 |
2017年 | 151篇 |
2016年 | 201篇 |
2015年 | 189篇 |
2014年 | 228篇 |
2013年 | 415篇 |
2012年 | 463篇 |
2011年 | 428篇 |
2010年 | 278篇 |
2009年 | 255篇 |
2008年 | 381篇 |
2007年 | 457篇 |
2006年 | 458篇 |
2005年 | 403篇 |
2004年 | 359篇 |
2003年 | 359篇 |
2002年 | 357篇 |
2001年 | 306篇 |
2000年 | 303篇 |
1999年 | 295篇 |
1998年 | 193篇 |
1997年 | 164篇 |
1996年 | 178篇 |
1995年 | 133篇 |
1994年 | 143篇 |
1993年 | 132篇 |
1992年 | 221篇 |
1991年 | 189篇 |
1990年 | 176篇 |
1989年 | 225篇 |
1988年 | 177篇 |
1987年 | 172篇 |
1986年 | 158篇 |
1985年 | 144篇 |
1984年 | 151篇 |
1983年 | 98篇 |
1982年 | 77篇 |
1981年 | 77篇 |
1980年 | 79篇 |
1979年 | 91篇 |
1978年 | 63篇 |
1977年 | 83篇 |
1975年 | 68篇 |
1971年 | 58篇 |
1965年 | 61篇 |
1964年 | 60篇 |
1960年 | 66篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Samawi Luma Williams Petal Petersen Myers Bronwyn Fuhr Daniela C 《Archives of women's mental health》2021,24(4):557-568
Archives of Women's Mental Health - This study aims to synthesise the available evidence on psychological interventions to reduce alcohol consumption among pregnant and postpartum women. Six... 相似文献
4.
5.
6.
best practice onkologie - Gallengangskarzinome werden entsprechend ihrer Lokalisation in distale, perihiläre und intrahepatische Cholangiokarzinome (CCA) unterteilt. Neben unterschiedlichen... 相似文献
7.
Erna Petersen Birna Thorisdottir Inga Thorsdottir Geir Gunnlaugsson Petra Arohonka Iris Erlund Ingibjrg Gunnarsdottir 《Maternal & child nutrition》2020,16(3)
Iodine is an essential nutrient for growth and development during infancy. Data on iodine status of exclusively (EBF) and partially breastfed (PBF) infants as well as breast milk iodine concentration (BMIC) are scarce. We aimed to assess (a) infant iodine nutrition at the age of 5.5 months by measuring urinary iodine concentration (UIC) in EBF (n = 32) and PBF (n = 28) infants and (b) mothers' breast milk iodine concentration (n = 57). Sixty mother–infant pairs from three primary health care centres in Reykjavik and vicinities provided urine and breast milk samples for iodine analysis and information on mothers' habitual diet. The mother–infant pairs were participants of the IceAge2 study, which focuses on factors contributing to infant growth and development, including body composition and breast‐milk energy content. The median (25th–75th percentiles) UIC was 152 (79–239) μg/L, with no significant difference between EBF and PBF infants. The estimated median iodine intake ranged from 52 to 86 μg/day, based on urinary data (assuming an average urine volume of 300–500 ml/day and UIC from the present study). The median (25th–75th percentiles) BMIC was 84 (48–114) μg/L. It is difficult to conclude whether iodine status is adequate in the present study, as no ranges for median UIC reflecting optimal iodine nutrition exist for infants. However, the results add important information to the relatively sparse literature on UIC, BMIC, and iodine intake of breastfed infants. 相似文献
8.
Marie Warrer Petersen Tine Sylvest Meyhoff Marie Helleberg Maj-Brit Nørregaard Kjær Anders Granholm Carl Johan Steensen Hjortsø Thomas Steen Jensen Morten Hylander Møller Peter Buhl Hjortrup Mik Wetterslev Gitte Kingo Vesterlund Lene Russell Vibeke Lind Jørgensen Klaus Tjelle Thomas Benfield Charlotte Suppli Ulrik Anne Sofie Andreasen Thomas Mohr Morten H. Bestle Lone Musaeus Poulsen Mette Friberg Hitz Thomas Hildebrandt Lene Surland Knudsen Anders Møller Christoffer Grant Sølling Anne Craveiro Brøchner Bodil Steen Rasmussen Henrik Nielsen Steffen Christensen Thomas Strøm Maria Cronhjort Rebecka Rubenson Wahlin Stephan Jakob Luca Cioccari Balasubramanian Venkatesh Naomi Hammond Vivekanand Jha Sheila Nainan Myatra Christian Gluud Theis Lange Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375
Introduction
Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.Methods
The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.Discussion
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.9.
10.